PL2264009T3 - Związek stanowiący kwas pirydyloaminooctowy - Google Patents
Związek stanowiący kwas pirydyloaminooctowyInfo
- Publication number
- PL2264009T3 PL2264009T3 PL09721163T PL09721163T PL2264009T3 PL 2264009 T3 PL2264009 T3 PL 2264009T3 PL 09721163 T PL09721163 T PL 09721163T PL 09721163 T PL09721163 T PL 09721163T PL 2264009 T3 PL2264009 T3 PL 2264009T3
- Authority
- PL
- Poland
- Prior art keywords
- acid compound
- pyridylaminoacetic acid
- pyridylaminoacetic
- compound
- acid
- Prior art date
Links
- 239000002253 acid Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/443—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Pulmonology (AREA)
- Biophysics (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Molecular Biology (AREA)
- Physical Education & Sports Medicine (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2008062926 | 2008-03-12 | ||
| EP09721163.5A EP2264009B1 (en) | 2008-03-12 | 2009-03-12 | Pyridylaminoacetic acid compound |
| PCT/JP2009/054713 WO2009113600A1 (ja) | 2008-03-12 | 2009-03-12 | ピリジルアミノ酢酸化合物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2264009T3 true PL2264009T3 (pl) | 2019-07-31 |
Family
ID=41065261
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL09721163T PL2264009T3 (pl) | 2008-03-12 | 2009-03-12 | Związek stanowiący kwas pirydyloaminooctowy |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US8648097B2 (pl) |
| EP (1) | EP2264009B1 (pl) |
| JP (3) | JP5136640B2 (pl) |
| KR (1) | KR101609001B1 (pl) |
| CN (2) | CN103965099A (pl) |
| AU (1) | AU2009224329B2 (pl) |
| CA (1) | CA2718393C (pl) |
| CY (1) | CY1121543T1 (pl) |
| DK (1) | DK2264009T3 (pl) |
| ES (1) | ES2718813T3 (pl) |
| HR (1) | HRP20190509T1 (pl) |
| HU (1) | HUE042839T2 (pl) |
| LT (1) | LT2264009T (pl) |
| PL (1) | PL2264009T3 (pl) |
| PT (1) | PT2264009T (pl) |
| SI (1) | SI2264009T1 (pl) |
| TR (1) | TR201904655T4 (pl) |
| WO (1) | WO2009113600A1 (pl) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUE042839T2 (hu) * | 2008-03-12 | 2019-07-29 | Ube Industries | Piridilaminoecetsav vegyületek |
| HRP20160104T1 (hr) | 2009-03-30 | 2016-03-25 | Ube Industries | Farmaceutski pripravak za liječenje ili prevenciju glaukoma |
| JP2011057633A (ja) * | 2009-09-11 | 2011-03-24 | Ube Industries Ltd | ピリジルアミノ酢酸化合物を含有する医薬 |
| WO2011030872A1 (ja) * | 2009-09-11 | 2011-03-17 | 宇部興産株式会社 | スルホンアミド化合物 |
| WO2011030873A1 (ja) * | 2009-09-11 | 2011-03-17 | 宇部興産株式会社 | ベンジル化合物 |
| JPWO2011030864A1 (ja) * | 2009-09-11 | 2013-02-07 | 宇部興産株式会社 | アニリン化合物 |
| WO2011030871A1 (ja) * | 2009-09-11 | 2011-03-17 | 宇部興産株式会社 | Ｎ－置換ヘテロアリール化合物 |
| WO2011030865A1 (ja) * | 2009-09-11 | 2011-03-17 | 宇部興産株式会社 | 置換ベンジル化合物 |
| AU2010293410A1 (en) * | 2009-09-11 | 2012-05-03 | Ube Industries, Ltd. | Substituted carbonyl compounds |
| EP2520570A4 (en) * | 2009-12-25 | 2013-07-17 | Ube Industries | aminopyridine compound |
| BR122017023123B1 (pt) | 2010-03-12 | 2018-04-24 | Nippon Soda Co., Ltd. | Método para produzir derivado de picolina halogenada |
| EP2547204A2 (de) | 2010-03-18 | 2013-01-23 | Bayer Intellectual Property GmbH | Aryl- und hetarylsulfonamide als wirkstoffe gegen abiotischen pflanzenstress |
| EP2471363A1 (de) | 2010-12-30 | 2012-07-04 | Bayer CropScience AG | Verwendung von Aryl-, Heteroaryl- und Benzylsulfonamidocarbonsäuren, -carbonsäureestern, -carbonsäureamiden und -carbonitrilen oder deren Salze zur Steigerung der Stresstoleranz in Pflanzen |
| JPWO2014157672A1 (ja) | 2013-03-28 | 2017-02-16 | 宇部興産株式会社 | 置換ビアリール化合物 |
| EP3042656A1 (en) * | 2013-09-02 | 2016-07-13 | UBE Industries, Ltd. | Pharmaceutical composition for treatment and/or prevention of pulmonary disease |
| ES2953346T3 (es) * | 2014-01-10 | 2023-11-10 | Santen Pharmaceutical Co Ltd | Composición farmacéutica que contiene un compuesto de ácido piridilaminoacético y aceite de ricino polioxietilenado |
| BR112016015909B1 (pt) | 2014-01-10 | 2020-09-29 | Santen Pharmaceutical Co., Ltd. | Composição farmacêutica contendo composto de ácido piridilaminoacético |
| GEP20186917B (en) | 2014-01-10 | 2018-11-12 | Pharmaceutical Co Ltd Santen | Pharmaceutical preparation including pyridylamino acetic acid compound |
| US10774072B2 (en) | 2014-06-10 | 2020-09-15 | Ube Industries, Ltd. | Crystal of N-substituted sulfonamide compound |
| CN106458904B (zh) | 2014-06-10 | 2021-12-03 | 宇部兴产株式会社 | N-取代磺酰胺化合物及其制造方法 |
| US10519112B2 (en) | 2014-06-10 | 2019-12-31 | Ube Industries, Ltd. | Method for producing heteroaromatic sulfonamide compound |
| JP2017206445A (ja) * | 2014-09-26 | 2017-11-24 | 宇部興産株式会社 | 呼吸器疾患の治療及び／又は予防のための医薬組成物 |
| JP2017206443A (ja) * | 2014-09-26 | 2017-11-24 | 宇部興産株式会社 | 置換ビアリール化合物及び他の医薬の組み合わせ |
| EP3320904B1 (en) | 2015-07-09 | 2023-07-05 | Santen Pharmaceutical Co., Ltd. | Preventative and/or therapeutic agent containing pyridyl aminoacetic acid compound for treating a disease involving a greatly elevated intraocular pressure |
| WO2018108627A1 (de) | 2016-12-12 | 2018-06-21 | Bayer Cropscience Aktiengesellschaft | Verwendung substituierter indolinylmethylsulfonamide oder deren salze zur steigerung der stresstoleranz in pflanzen |
| WO2019025153A1 (de) | 2017-07-31 | 2019-02-07 | Bayer Cropscience Aktiengesellschaft | Verwendung von substituierten n-sulfonyl-n'-aryldiaminoalkanen und n-sulfonyl-n'-heteroaryldiaminoalkanen oder deren salzen zur steigerung der stresstoleranz in pflanzen |
| TWI842679B (zh) | 2017-09-29 | 2024-05-21 | 日商參天製藥股份有限公司 | 含有吡啶基胺乙酸化合物之醫藥 |
| WO2019124487A1 (ja) | 2017-12-21 | 2019-06-27 | 参天製薬株式会社 | オミデネパグの組合せ |
| CN111526876A (zh) | 2017-12-28 | 2020-08-11 | 参天制药株式会社 | 含有吡啶基氨基乙酸化合物的药物制剂 |
| CN118084895B (zh) * | 2024-02-28 | 2025-09-05 | 中国药科大学 | 一种一氧化氮供体型Omidenepag衍生物及其制备方法和应用 |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH06509211A (ja) | 1990-06-08 | 1994-10-13 | エスピーエス・テクノロジーズ・インコーポレーテッド | 改良磁性材料及びその製造方法 |
| TW523506B (en) | 1996-12-18 | 2003-03-11 | Ono Pharmaceutical Co | Sulfonamide or carbamide derivatives and drugs containing the same as active ingredients |
| UA59384C2 (uk) | 1996-12-20 | 2003-09-15 | Пфайзер, Інк. | Похідні сульфонамідів та амідів як агоністи простагландину, фармацевтична композиція та способи лікування на їх основі |
| UA67754C2 (uk) * | 1997-10-10 | 2004-07-15 | Пфайзер, Інк. | Агоністи простагландину, фармацевтична композиція на їх основі (варіанти), спосіб нарощення та збереження кісткової маси у хребетних та спосіб лікування (варіанти) |
| TR200002182T2 (tr) | 1998-01-27 | 2000-12-21 | Aventis Pharmaceuticals Products Inc. | İkame edilmiş aksozaherosayklil faktör xa inhibitörleri |
| AU2001290250A1 (en) | 2000-09-21 | 2002-04-02 | Ono Pharmaceutical Co. Ltd. | Ep4 receptor agonists containing 8-azaprostaglandin derivatives as the active ingredient |
| MXPA04001253A (es) | 2001-08-09 | 2004-06-03 | Ono Pharmaceutical Co | Derivados de acidos carboxilicos y agente farmaceutico que comprende los mismos como ingrediente activo. |
| DE60118628T2 (de) | 2001-10-26 | 2007-02-15 | Allergan, Inc., Irvine | Omega-cycloalkyl 17-heteroaryl prostaglandin e2 analogen als ep2-rezeptor agonisten |
| PY0300568A (es) | 2002-01-31 | 2004-10-01 | Pfizer Prod Inc | Metabolitos del acido(3-{[4-terc-butilbencil)-(piridin-3-sulfonil)amino]metil}fenoxi)acetico |
| AU2003211574A1 (en) | 2002-03-05 | 2003-09-16 | Ono Pharmaceutical Co., Ltd. | 8-azaprostaglandin derivative compounds and drugs containing the compounds as the active ingredient |
| NZ541828A (en) * | 2003-03-04 | 2008-06-30 | Pfizer Prod Inc | Use of EP2 selective receptor agonists in medical treatment |
| GB0329620D0 (en) | 2003-12-22 | 2004-01-28 | Pharmagene Lab Ltd | EP2 receptor agonists |
| JP2007186424A (ja) | 2004-11-26 | 2007-07-26 | Ono Pharmaceut Co Ltd | 気管支拡張剤 |
| WO2005072743A1 (ja) | 2004-01-30 | 2005-08-11 | Ono Pharmaceutical Co., Ltd. | 気管支拡張剤 |
| ES2564804T3 (es) | 2004-02-12 | 2016-03-29 | Mitsubishi Tanabe Pharma Corporation | Compuesto de indazol y uso farmacéutico del mismo |
| EP1593671A1 (en) | 2004-03-05 | 2005-11-09 | Graffinity Pharmaceuticals AG | DPP-IV inhibitors |
| EP1765332A2 (en) | 2004-06-17 | 2007-03-28 | Cengent Therapeutics, Inc. | Trisubstituted nitrogen modulators of tyrosine phosphatases |
| GB0415320D0 (en) | 2004-07-08 | 2004-08-11 | Astrazeneca Ab | Novel compounds |
| AU2006205920B2 (en) | 2005-01-14 | 2012-11-15 | F. Hoffmann-La Roche Ag | Thiazole-4-carboxamide derivatives as mGluR5 antagonists |
| JP4874958B2 (ja) | 2005-03-30 | 2012-02-15 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | ピリジン誘導体を含有する抗真菌剤 |
| US20090270395A1 (en) | 2005-08-03 | 2009-10-29 | John Colucci | EP4 Receptor Agonist, Compositions and Methods Thereof |
| CA2618486A1 (en) | 2005-08-09 | 2007-02-15 | Asterand Uk Limited | Ep2 receptor agonists |
| US7696235B2 (en) | 2005-08-29 | 2010-04-13 | Allergan, Inc. | EP2 receptor agonists for treating glaucoma |
| UA94953C2 (en) * | 2006-07-28 | 2011-06-25 | Пфайзер Продактс Инк. | Ep2 agonists |
| EP2059507B1 (en) | 2006-07-28 | 2013-03-20 | Pfizer Products Inc. | Ep2 agonist |
| HUE042839T2 (hu) | 2008-03-12 | 2019-07-29 | Ube Industries | Piridilaminoecetsav vegyületek |
| HRP20160104T1 (hr) * | 2009-03-30 | 2016-03-25 | Ube Industries | Farmaceutski pripravak za liječenje ili prevenciju glaukoma |
-
2009
- 2009-03-12 HU HUE09721163A patent/HUE042839T2/hu unknown
- 2009-03-12 SI SI200931953T patent/SI2264009T1/sl unknown
- 2009-03-12 LT LTEP09721163.5T patent/LT2264009T/lt unknown
- 2009-03-12 WO PCT/JP2009/054713 patent/WO2009113600A1/ja not_active Ceased
- 2009-03-12 EP EP09721163.5A patent/EP2264009B1/en active Active
- 2009-03-12 HR HRP20190509TT patent/HRP20190509T1/hr unknown
- 2009-03-12 CN CN201410213200.5A patent/CN103965099A/zh active Pending
- 2009-03-12 PL PL09721163T patent/PL2264009T3/pl unknown
- 2009-03-12 PT PT09721163T patent/PT2264009T/pt unknown
- 2009-03-12 ES ES09721163T patent/ES2718813T3/es active Active
- 2009-03-12 TR TR2019/04655T patent/TR201904655T4/tr unknown
- 2009-03-12 US US12/922,028 patent/US8648097B2/en active Active
- 2009-03-12 KR KR1020107022680A patent/KR101609001B1/ko active Active
- 2009-03-12 CN CN200980108500.4A patent/CN101970410B/zh active Active
- 2009-03-12 AU AU2009224329A patent/AU2009224329B2/en active Active
- 2009-03-12 DK DK09721163.5T patent/DK2264009T3/en active
- 2009-03-12 CA CA2718393A patent/CA2718393C/en active Active
- 2009-03-12 JP JP2010502864A patent/JP5136640B2/ja active Active
-
2012
- 2012-11-15 JP JP2012251011A patent/JP5545344B2/ja not_active Expired - Fee Related
-
2013
- 2013-12-16 US US14/108,029 patent/US20140113907A1/en not_active Abandoned
-
2014
- 2014-05-14 JP JP2014100287A patent/JP2014177476A/ja active Pending
-
2019
- 2019-03-28 CY CY20191100359T patent/CY1121543T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PT2264009T (pt) | 2019-04-29 |
| CY1121543T1 (el) | 2020-05-29 |
| AU2009224329B2 (en) | 2013-11-07 |
| EP2264009B1 (en) | 2019-03-06 |
| JP2013063994A (ja) | 2013-04-11 |
| KR20100123903A (ko) | 2010-11-25 |
| ES2718813T3 (es) | 2019-07-04 |
| CN103965099A (zh) | 2014-08-06 |
| HRP20190509T1 (hr) | 2019-05-03 |
| CN101970410B (zh) | 2014-06-25 |
| LT2264009T (lt) | 2019-04-25 |
| CA2718393A1 (en) | 2009-09-17 |
| DK2264009T3 (en) | 2019-04-15 |
| HUE042839T2 (hu) | 2019-07-29 |
| KR101609001B1 (ko) | 2016-04-04 |
| JPWO2009113600A1 (ja) | 2011-07-21 |
| AU2009224329A1 (en) | 2009-09-17 |
| US20110054172A1 (en) | 2011-03-03 |
| US8648097B2 (en) | 2014-02-11 |
| US20140113907A1 (en) | 2014-04-24 |
| CA2718393C (en) | 2015-06-16 |
| CN101970410A (zh) | 2011-02-09 |
| SI2264009T1 (sl) | 2019-05-31 |
| EP2264009A4 (en) | 2012-08-01 |
| EP2264009A1 (en) | 2010-12-22 |
| JP5545344B2 (ja) | 2014-07-09 |
| JP2014177476A (ja) | 2014-09-25 |
| JP5136640B2 (ja) | 2013-02-06 |
| WO2009113600A1 (ja) | 2009-09-17 |
| TR201904655T4 (tr) | 2019-06-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUE042839T2 (hu) | Piridilaminoecetsav vegyületek | |
| ZA201008096B (en) | Carboxylic acid compound | |
| GB0818033D0 (en) | Novel compound | |
| SI2192109T1 (sl) | Biciklični aminokislinski derivati | |
| GB0800035D0 (en) | Compounds | |
| GB0804989D0 (en) | Compound | |
| ZA201000869B (en) | Phenylacetic acid compound | |
| GB0803494D0 (en) | Compound | |
| IL207035A0 (en) | Benzylpiperizine compound | |
| IL206524A0 (en) | 4-dimethylminobutyric acid derivatives | |
| GB0800367D0 (en) | Compounds | |
| GB0823316D0 (en) | Compound | |
| GB0801220D0 (en) | Compounds | |
| GB0801265D0 (en) | Compounds | |
| GB0802227D0 (en) | Compound | |
| GB0820916D0 (en) | Compound | |
| GB0807158D0 (en) | Compound | |
| GB0806005D0 (en) | Compound | |
| GB0815806D0 (en) | Compound | |
| GB0820919D0 (en) | Compound | |
| GB0820918D0 (en) | Compound | |
| GB0822635D0 (en) | Compound | |
| GB0812580D0 (en) | Compound | |
| GB0805430D0 (en) | Compound | |
| GB0806844D0 (en) | Compound |